Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Clobetasol Propionate, and what generic Clobetasol Propionate alternatives are available?

Clobetasol Propionate is a drug marketed by Perrigo Israel, Taro, Wockhardt, Fougera Pharms, Akorn, Actavis Mid Atlantic, Perrigo Co, G And W Labs Inc, Glenmark Pharms, Mylan Pharms Inc, Teligent Pharma Inc, Novel Labs Inc, Tolmar, Zydus Pharms Usa Inc, Teva Pharms Usa, Fougera Pharms Inc, Paddock Llc, and Ingenus Pharms Llc. and is included in thirty-five NDAs.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for Tradename: CLOBETASOL PROPIONATE

Suppliers / Packagers: see list23
Bulk Api Vendors: see list40
Clinical Trials: see list123
Patent Applications: see list4,953
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
clobetasol propionate
SPRAY;TOPICAL090898-001Jun 16, 2011ATRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
clobetasol propionate
CREAM;TOPICAL074087-001Feb 16, 1994DISCNNoNo► Subscribe► Subscribe
Fougera Pharms
clobetasol propionate
CREAM;TOPICAL075430-001May 26, 1999AB2RXNoYes► Subscribe► Subscribe
G And W Labs Inc
clobetasol propionate
OINTMENT;TOPICAL074089-001Feb 16, 1994ABRXNoNo► Subscribe► Subscribe
Perrigo Israel
clobetasol propionate
AEROSOL, FOAM;TOPICAL201402-001Aug 14, 2012AB2RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus